Often, newspapers, magazines and other print publications choose to feature the OmniPod and the people who use it. When possible, we archive these articles for your perusal. Simply click the links below to read more.

 

Please note, you must have Adobe^® Acrobat Reader^® on your computer to view many of these articles. If you do not have this software, you can download a free copy.

 

In Silico Evaluation Platform for Artificial Pancreatic b-Cell Development—A Dynamic Simulator for Closed-Loop Control with Hardware-in-the-Loop

Diabetes Technology & Therapeutics, 2009
Researchers at the University of California Santa Barbara, Sansum Diabetes Research Institute and Stanford Medical Center successfully created a computer-simulated system to evaluate an artificial pancreas. The “pancreas” is comprised of the OmniPod System and a continuous glucose monitor, governed by an algorithm. The study, funded by the JDRF, streamlines preclinical validation trials, bringing the artificial pancreas closer to reality.
From Diabetes Technology & Therapeutics, Vol 11, 2009; 187-194.
This article was written for research purposes only. Insulet makes no real or implied claims concerning the suitability of this technology for diabetes management using the OmniPod Diabetes Management System.  

 

One Road to Hope: JDRF’s Artificial Pancreas Project at the University of Virginia

In this video, found on the JDRF site, researchers at the University of Virginia Health System, patients and diabetes advocates describe the JDRF Artificial Pancreas Project and its potential impact; then one patient documents his experiences with the clinical trial.

 

This video was made for research purposes only. Insulet makes no real or implied claims concerning the suitability of this technology for diabetes management using the OmniPod Diabetes Management System.

 

Pumped Up

November 2008

This HealthMatters story on the history of insulin pumps features Ironwoman Triathlete and OmniPod user Kathy Gagnier. Kathy finds that pump therapy makes her diabetes easier to manage. Note: Kathy personalizes the look of all of her pods with permanent markers. Used by permission of HealthMatters For People With Diabetes and Liberty Medical.

 

Positive Update: Adventure Photographer Lisa Seaman

March 2008
Diabetes Positive! profiles outdoorswoman and adventure photographer Lisa Seaman. An enthusiastic pumper, Lisa recently switched to OmniPod—and she talks about how the System helps her lead her active lifestyle.

 

Sky Radio interview with Shawna Gvazdauskas

March 2008

Sky Radio—renowned producers of business, technology and health programming for the airlines and internet—spoke with Insulet’s then Senior Vice President of Sales & Marketing Shawna Gvazdauskas about how the OmniPod System works, and how it is making diabetes a smaller part of life for thousands.

 

Quantifying the Impact of a Short-Interval Interruption of Insulin-Pump Infusion Sets on Glycemic Excursions
Diabetes Care, 2008

A prospective, open-label study measured the impact of short-term infusion set disconnects on glucose levels. It shows that even short-term interruption of insulin delivery can cause blood glucose levels to rise and remain elevated for hours post-interruption.
Copyright © 2008 American Diabetes Association
From Diabetes Care^®, Vol. 31, 2008; 238-239
Reprinted with permission from The American Diabetes Association.

 

The OmniPod Insulin Management System

November 2007

In a cover story, Diabetes Positive! explores the history of the OmniPod and its advantages over conventional pumps—including its lower start-up costs. Interviewee Anthony Vita notes that the System “has given [him] back [his] life.”

 

Insulet signs deal to ramp up insulin pump supply

October 4, 2007

Reuters reports that a new deal with Flextronics, one of the largest suppliers of blood glucose meters, will boost Insulet’s production capacity; it further speculates that the OmniPod System’s relative convenience may help encourage more people with Type 2 diabetes to use insulin pumps.

 

diaTribe: Test Driving Insulet’s OmniPod System

May/June 2007

diaTribe columnist Kelly Close describes her experience with OmniPod, including details of how the System works and how she compares it to other pumps she has used. Close’s conclusion: She would sacrifice her cell phone for an OmniPod.

 

OmniPod Insulin Management System: Patient perceptions, preference and glycemic control

September 2006

Diabetes researchers Howard Zisser, MD and Lois Jovanovic, MD detail the results of a 30-day study comparing the OmniPod with conventional insulin pump therapy along metrics of glycemic control, convenience, insertion pain and satisfaction. Subjects showed remarked preference for the OmniPod; importantly, they also showed significantly reduced A1C values.
Copyright^© 2006 American Diabetes Association
From Diabetes Care, Vol. 29, 2006; 2175
Reprinted with permission from The American Diabetes Association.

 

A ‘Gadget Guy’ Embraces Diabetes

July 2006

Diabetes Health interviews The Diabetic Investor editor David Kliff, on life with the OmniPod System, including his lower A1Cs and the freedom of having no tubing.

 

Insulin Pump Therapy: A meta-analysis
Diabetes Care, 2003
Examining the metabolic and psychosocial impact of insulin pump therapy, this study concluded that insulin pumps improve glycemic control as compared with other therapies.
Copyright © 2003 American Diabetes Association
From Diabetes Care^®, Vol. 26, 2003; 1079-1087
Reprinted with permission from The American Diabetes Association.

 

Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Regimens Using Insulin Lispro in Type 1 Diabetic Patients on Intensified Treatment
Diabetes Care, 2000
A randomized study compared the efficacy of two treatment regimes: continuous subcutaneous insulin infusion (insulin pump therapy) and multiple daily injections (MDI). Subjects using insulin pumps achieved much better glycemic control using less insulin than subjects using MDI.
Copyright © 2000 American Diabetes Association
From Diabetes Care^®, Vol. 23, 2000; 1232-1235
Reprinted with permission from The American Diabetes Association.

 

Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes
Diabetes Care, 1996
This study compared the incidence of severe hypoglycemia in patients who switched to continuous subcutaneous insulin infusion (CSII) from multiple daily injections (MDI). It concluded that CSII therapy produced a “marked and sustained reduction” in hypoglycemia, due to the reproducible and flexible insulin delivery.
Copyright © 1996 American Diabetes Association
From Diabetes Care^®, Vol. 19, 1996; 324-327
Reprinted with permission from The American Diabetes Association.